ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
---|---|---|---|---|
10000319 | TYYMSAGLQPVPIVFR | S | 134 | |
10000386 | TIRPMDIEAIEASVMK | S | 13 | 282 |
10008873 | TIRPMDIEAIEASVMK | S | 13 | 282 |
ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
---|---|---|---|---|---|---|---|---|---|---|
10000319 | MS | HTP | unambiguous | rat | cardiac mitochondria | TMG/control | -1.177376088 | 26446791 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
10000386 | MS | HTP | unambiguous | rat | heart | diabetic/control | 0.370575436 | 27213235 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
10008873 | MS | HTP | unambiguous | rat | heart (mitochondria) | 27213235 |
ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
10000319 | TYYMSAGLQPVPIVFR | S | 134 | MS | HTP | unambiguous | rat | cardiac mitochondria | 26446791 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
10000386 | TIRPMDIEAIEASVMK | S | 13 | 282 | MS | HTP | unambiguous | rat | heart | 27213235 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. |
10008873 | TIRPMDIEAIEASVMK | S | 13 | 282 | MS | HTP | unambiguous | rat | heart (mitochondria) | 27213235 |